Characterization of CD3+ T Lymphocytes in Human Coronary Thrombi with ST-segment Elevation Myocardial Infarction

Muyang Gu1,2,3, Ni Xia1,2,3, Si Zhang1,2,3

  • 1Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

PubMed

Insights

This study reveals increased T cell clonality in ST-segment elevation myocardial infarction (STEMI) coronary thrombi, suggesting specific immune responses drive atherothrombosis and offering new therapeutic targets.

Area of Science:

  • Immunology
  • Cardiovascular Medicine
  • Genomics

Background:

  • ST-segment elevation myocardial infarction (STEMI) involves coronary atherothrombosis, where immune responses play a key role.
  • The exact causes of atherothrombosis and the specific T cell-mediated immune responses in STEMI coronary thrombi remain unclear.

Purpose of the Study:

  • To investigate the heterogeneity and clonality of CD3+ T lymphocytes within STEMI coronary thrombi and peripheral blood at a single-cell level.

Main Methods:

  • Single-cell RNA and T cell receptor (TCR) sequencing were employed.
  • Analysis included CD3+ T lymphocytes from STEMI coronary thrombi, peripheral blood of STEMI patients, and blood from non-coronary artery disease (CAD) controls.

Main Results:

  • CD3+ T lymphocytes in STEMI coronary thrombi showed reduced activation, cytotoxicity, and pro-inflammatory/pro-thrombotic characteristics compared to peripheral blood.
  • Increased CD3+ T cell clonality was observed in coronary thrombi.
  • T lymphocytes from STEMI patients displayed upregulated genes linked to recent TCR engagement, indicating antigen-specific stimulation and potential shared antigen targets across patients.

Conclusions:

  • This research elucidates the cellular heterogeneity of CD3+ T lymphocytes in STEMI.
  • Understanding the adaptive immune mechanisms in atherothrombosis can pave the way for targeted therapies against aberrant immune responses for improved STEMI treatment.
Abstract

Related Concept Videos

Myocarditis II: Clinical features and Diagnostic Tests01:27

Myocarditis II: Clinical features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
2
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
2
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
671